Regenerative medicine in spine and orthopedics is gaining momentum, and many surgeons expect further development and research for the field in the near future.
Bioventus has exercised its call option to acquire Israeli devicemaker CartiHeal for up to $450 million following the FDA's premarket approval of the Agili-C implant on March 29.
Surgeons at Yale Medicine in New Haven, Conn., are using stem cell treatments to treat some hip conditions without joint replacements, ABC affiliate WTNH reported March 1.
The Becker's Spine Review website uses cookies to display relevant ads and to enhance your browsing experience. By continuing to use our site, you acknowledge that you have read, that you understand, and that you accept our Cookie Policy and our Privacy Policy.
